Aptose Biosciences INC. (APTOF) — SC 13D/A Filings

All SC 13D/A filings from Aptose Biosciences INC.. Browse 2 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (2)

Hanmi Pharma Amends Stake in Aptose Biosciences — Apr 26, 2024 Risk: medium
Hanmi Pharmaceutical Co., Ltd. has filed an amendment (No. 2) to its Schedule 13D for Aptose Biosciences Inc. on April 26, 2024. This filing indicates a change
Hanmi Pharma Amends Aptose Biosciences 13D Filing — Feb 5, 2024
Hanmi Pharmaceutical Co., Ltd. filed an Amendment No. 1 to Schedule 13D on February 5, 2024, updating its previous filing regarding its ownership in Aptose Bios

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX